Published in Gene Therapy Weekly, December 7th, 2000
The results were reported November 12, 2000, at the American Heart Association's Scientific Sessions 2000, held in New Orleans, Louisiana.
Since gene therapy is used to stimulate the growth of new blood vessels, there has been concern that therapy may lead to overgrowth of other cells in the body, increasing the risk for cancer or other problems. Among 102 patients in the study, there were no significant differences in deaths, heart attacks, or cancer over the course of one...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.